EUVIMEDEUVIMED entdecken
Crossref

Euglycemic Diabetic Ketoacidosis in the Era of SGLT2 Inhibitors: Epidemiology, Mechanisms, Diagnosis, Prevention, and Future Perspectives

Naina Mohamed Pakkir Maideen, Sulthan Al Rashid, Rajkapoor Balasubramanian, Deepika Vishwanathan, Arun Shanmugam

SN Comprehensive Clinical Medicine · 13.07.2026 · 8 (1)

DOI: 10.1007/s42399-026-02540-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SN Comprehensive Clinical Medicine, online erschienen am 13.07.2026. Verfasst von Naina Mohamed Pakkir Maideen und 4 weiteren Autor:innen. Die Arbeit nennt 88 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Maideen, N. M. P., Rashid, S. A., Balasubramanian, R., Vishwanathan, D., & Shanmugam, A. (2026). Euglycemic Diabetic Ketoacidosis in the Era of SGLT2 Inhibitors: Epidemiology, Mechanisms, Diagnosis, Prevention, and Future Perspectives. SN Comprehensive Clinical Medicine, 8(1). https://doi.org/10.1007/s42399-026-02540-3

Vancouver

Maideen NMP, Rashid SA, Balasubramanian R, Vishwanathan D, Shanmugam A. Euglycemic Diabetic Ketoacidosis in the Era of SGLT2 Inhibitors: Epidemiology, Mechanisms, Diagnosis, Prevention, and Future Perspectives. SN Comprehensive Clinical Medicine. 2026;8(1). doi:10.1007/s42399-026-02540-3

BibTeX
@article{Maideen2026,
  author = {Maideen, Naina Mohamed Pakkir and Rashid, Sulthan Al and Balasubramanian, Rajkapoor and Vishwanathan, Deepika and Shanmugam, Arun},
  title = {Euglycemic Diabetic Ketoacidosis in the Era of SGLT2 Inhibitors: Epidemiology, Mechanisms, Diagnosis, Prevention, and Future Perspectives},
  journal = {SN Comprehensive Clinical Medicine},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1007/s42399-026-02540-3}
}
Kostenlos starten →